http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IE-41256-L
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7ad58d3c0b071069a8ee0cb8c8ba2e8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 |
| filingDate | 1975-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1975-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | IE-41256-L |
| titleOfInvention | 1-[2-(ß-NAPHTHYLOXY)-ETHYL]-3-METHYL-PYRAZOLIN-5-ONE |
| abstract | 1454733 1 - (2 - Beta - naphthoxyethyl)- 3 - methylpyrazolin - 5 - one BAYER AG 6 May 1975 [6 June 1974 11 July 1974] 18970/75 Heading C2C The invention comprises the title compound and its salts. In examples, it is prepared by reacting (1) 2-beta-naphthoxyethylhydrazine with an alkyl or benzyl acetoacetate or tetrolate, or (2) a 2-beta-naphthoxyethyl halide with 3-methylpyrazolin-5-one or its sodium derivative. Therapeutic compositions having antithrombotic and thrombolytic activity comprise the above compound or its salts, and may be administered orally, parenterally or rectally. |
| priorityDate | 1974-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 21.